However, the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for anemia indicates that increasing Hb values from 11.5 to 13 g/dL has to be weighed against the probability of greater harm in CKD patients. This evidence concerns the gene GSTM1 and chronic kidney disease.